Evidence map›Paper›PMID 26681768›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2017

Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.

Shanyan Chen, Jiankun Cui, Tao Jiang, Emilia S Olson, Quan-Yu Cai, Ming Yang, Wei Wu, James M Guthrie, J D Robertson, Stuart A Lipton and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. The Advances and Biomedical Applications of Imageable Nanomaterials.Frontiers in bioengineering and biotechnology · 2022
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Theranostics · 2018
    Review
  11. Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Industrial & engineering chemistry research · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Shanyan ChenDepartment of Pathology and Anatomical Sciences, University of Missouri at Columbia, USA.
Jiankun CuiDepartment of Pathology and Anatomical Sciences, University of Missouri at Columbia, USA.
Tao JiangDepartment of Pharmacology, University of California San Diego School of Medicine, USA.
Emilia S OlsonDepartment of Pharmacology, University of California San Diego School of Medicine, USA.
Quan-Yu CaiTruman VA Hospital Research Service.
Ming YangTruman VA Hospital Research Service.
Wei WuDepartment of Pathology and Anatomical Sciences, University of Missouri at Columbia, USA.
James M GuthrieResearch Reactor Center, University of Missouri at Columbia, USA.
J D RobertsonResearch Reactor Center, University of Missouri at Columbia, USA.
Stuart A LiptonDepartment of Neurosciences, University of California San Diego School of Medicine, USA.
Lixin MaTruman VA Hospital Research Service.
Roger Y TsienDepartment of Pharmacology, University of California San Diego School of Medicine, USA.
Zezong GuDepartment of Pathology and Anatomical Sciences, University of Missouri at Columbia, USA guze@health.missouri.edu.
University of Missouri · USHarry S. Truman Memorial Veterans' Hospital · USUniversity of California, San Diego · USHoward Hughes Medical Institute · USScintillon Institute · US

Funding

PROJECT III - GENETIC APPROACH TO EXCITATORY TRANSMISSIONP01HD029587 · NICHD · SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · PI LIPTON, STUART A · 1992 to 2016
$21.9M
Project-002P30NS076411 · NINDS · SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · PI LIPTON, STUART A · 2011 to 2016
$4.5M
Injectable reporters to image tumors and guide resectionR01CA158448 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NGUYEN, QUYEN · 2011 to 2015
$3.1M
Modeling Parkinson's Disease with Isogenic hiPSC-Derived Dopaminergic NeuronsR01NS086890 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI LIPTON, STUART A · 2014 to 2018
$2.1M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA158448NICHD NIH HHS P01 HD029587NINDS NIH HHS P30 NS076411NINDS NIH HHS R01 NS086890
6 · The paper itself

Abstract

Matrix metalloproteinases (MMPs), particularly gelatinases (MMP-2/-9), are involved in neurovascular impairment after stroke. Detection of gelatinase activity in vivo can provide insight into blood-brain barrier disruption, hemorrhage, and nerve cell injury or death. We applied gelatinase-activatable cell-penetrating peptides (ACPP) with a cleavable l-amino acid linker to examine gelatinase activity in primary neurons in culture and ischemic mouse brain in vivo We found uptake of Cy5-conjugated ACPP (ACPP-Cy5) due to gelatinase activation both in cultured neurons exposed to n-methyl-d-aspartate and in mice after cerebral ischemia. Fluorescence intensity was significantly reduced when cells or mice were treated with MMP inhibitors or when a cleavage-resistant ACPP-Cy5 was substituted. We also applied an ACPP dendrimer (ACPPD) conjugated with multiple Cy5 and/or gadolinium moieties for fluorescence and magnetic resonance imaging (MRI) in intact animals. Fluorescence analysis showed that ACPPD was detected in sub-femtomole range in ischemic tissues. Moreover, MRI and inductively coupled plasma mass spectrometry revealed that ACPPD produced quantitative measures of gelatinase activity in the ischemic region. The resulting spatial pattern of gelatinase activity and neurodegeneration were very similar. We conclude that ACPPs are capable of tracing spatiotemporal gelatinase activity in vivo, and will therefore be useful in elucidating mechanisms of gelatinase-mediated neurodegeneration after stroke.

Indexed as

AnimalsBrain IschemiaCarbocyaninesCell-Penetrating PeptidesCells, CulturedGelatinasesMagnetic Resonance ImagingMatrix Metalloproteinase 2Matrix Metalloproteinase 9MiceMolecular ProbesNeurodegenerative DiseasesStrokeCarbocyaninesCell-Penetrating Peptidescyanine dye 5GelatinasesMatrix Metalloproteinase 2Matrix Metalloproteinase 9Molecular ProbesFocal ischemiamatrix proteinsmolecular imagingMRIneurodegeneration

Identifiers

PMID26681768
PMCPMC5363737
OpenAlexW2411750529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.